Impact of the SARS-CoV-2 virus on male reproductive health

Area of Science:

• Reproductive Medicine
• Infectious Diseases
• Andrology

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, disproportionately affects men, leading to more severe disease and higher mortality.
• Androgens and their receptors are implicated in COVID-19 severity, potentially increasing viral entry and infection rates.
• Male reproductive organs are vulnerable to SARS-CoV-2 infection, with viral particles found in penile and testicular tissues.

Purpose of the Study:

• To review the impact of SARS-CoV-2 infection on male reproductive health.
• To discuss the potential mechanisms linking COVID-19 to male reproductive dysfunction.
• To highlight the long-term consequences of SARS-CoV-2 on male fertility and hormonal balance.

Main Methods:

• This is a review article, synthesizing existing research on COVID-19 and male reproductive health.
• Literature search was conducted to identify studies reporting on viral presence in male reproductive organs and associated pathologies.
• Analysis of reported cases of erectile dysfunction, orchitis, and changes in sperm parameters in COVID-19 patients.

Main Results:

• COVID-19 infection can lead to germ cell and Leydig cell depletion in the testes.
• This depletion can result in decreased spermatogenesis and the development of male hypogonadism.
• While sexual transmission is unlikely, the virus can cause lasting damage to male reproductive function.

Conclusions:

• SARS-CoV-2 poses a significant threat to male reproductive health, potentially causing long-term damage.
• Further research is needed to fully elucidate the mechanisms and long-term sequelae of COVID-19 on the male reproductive system.
• Understanding these impacts is crucial for managing patient health and addressing fertility concerns post-infection.